Terumo Corp (TSE:4543)
円 2603.5 24 (0.93%) Market Cap: 3.87 Til Enterprise Value: 3.91 Til PE Ratio: 39.14 PB Ratio: 3.18 GF Score: 95/100

Q1 2022 Terumo Corp Earnings Call Transcript

Aug 04, 2021 / 08:00AM GMT
Release Date Price: 円2133 (-1.18%)
Naoki Muto
Terumo Corporation - Chief Accounting & Financial Officer and Executive Officer

I am the CAFO, Muto. I will now explain the first quarter results for the fiscal year ending March 2022.

First, the highlights from the quarter. Sales revenue was our highest ever for a quarter. In particular, a notable recovery of demand appeared in the Cardiac and Vascular Company, which had been greatly impacted by COVID-19. In FX, the dollar and euro both had a positive effect for Terumo. Adjusted operating profit was also the highest ever for a quarter. Along with the recovery in sales, improvement in product mix also pushed profitability upward. Negative impacts, including production adjustment and national tenders in China, had their expected effects, but expenses rose only gradually due to COVID-19. Taking into account these first quarter results, we are revising upward our guidance for this fiscal year. I will explain that in detail later in this presentation.

Next slide, please. Here are the P&L results for the first quarter. Sales revenue exceeded JPY 170 billion, and adjusted

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot